Review of intermittent preventive treatment for malaria in infants and children

Journal of Paediatrics and Child Health

Volumn 43, Issue 6, 2007, Pages 424-428

  Munday, Sally ^a  

^a JAMES COOK UNIVERSITY   (Australia)

Author keywords

Child; Infant; International child health; Malaria; Prevention and control

Indexed keywords

AMODIAQUINE; ANTIMALARIAL AGENT; ARTEMETHER PLUS BENFLUMETOL; ARTESUNATE; CHLORPROGUANIL PLUS DAPSONE; DIHYDROARTEMISININE PLUS PIPERAQUINE; MALARIA VACCINE; MEFLOQUINE; PLACEBO; UNCLASSIFIED DRUG;

CHILD; CLINICAL TRIAL; HUMAN; IMMUNIZATION; INFANT; INFECTION CONTROL; INFECTION PREVENTION; MALARIA; MALARIA CONTROL; MORBIDITY; PARASITEMIA; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; REVIEW;

ANTIMALARIALS; CHILD; HUMANS; INFANT; MALARIA;

EID: 34249068479     PISSN: 10344810     EISSN: 14401754     Source Type: Journal    
DOI: 10.1111/j.1440-1754.2007.01105.x     Document Type: Review

References (37)

1. Greenwood B, Bojang K, Whitty C, Targett G. Malaria. Lancet 2005 365: 1487 98.
2. Geerligs PDP, Brabin BJ, Eggelte TA. Analysis of the effects of malaria chemoprophylaxis in children on haematological responses, morbidity and mortality. Bull. World Health Organ. 2003 81: 205 16.
3. Greenwood B. The use of anti-malarial drugs to prevent malaria in the population of malaria endemic areas. Am. J. Trop. Med. Hyg. 2004 70: 1 7.
4. McGregor I, Gilles H, Walter J, Davies A, Pearson F. Effects of heavy and repeated malaria infections on Gambian infants and children. Effects of erythrocyte parasitization. BMJ 1956 ii: 313 22.
5. Menendez C, Kahigwa E, Hirt R et al. Randomised placebo-controlled trial of iron supplementation and malaria chemoprophylaxis for prevention of severe anaemia and malaria in Tanzanian infants. Lancet 1997 350: 844 50.
6. Greenwood B, David P, Otoo-Phorbes L. Mortality and morbidity from malaria after stopping malaria chemoprophylaxis. Trans. R. Soc. Trop. Med. Hyg. 1995 89: 629 33.
7. Schulman C, Dorman E. Importance and prevention of malaria in pregnancy. Trans. R. Soc. Trop. Med. Hyg. 2003 97: 30 5.
8. White N. Intermittent presumptive treatment for malaria. PLoS Med. 2005 2: 28 33.
9. Crawley J. Reducing the burden of anaemia in infants and young children in malaria-endemic countries of Africa: from evidence to action. Am. J. Trop. Med. Hyg. 2004 71 (2 Suppl. 25 34.
10. Rogerson S, Chaluluka E, Kanjala M, Mkundika P, Mhango C, Molyneux M. Intermittent sulfadoxine-pyrimethamine in pregnancy: effectiveness against malaria morbidity in Blantyre, Malawi, in 1997-1999. Trans. R. Soc. Trop. Med. Hyg. 2000 94: 549 53.
11. Shulman C, Dorman E, Cutts F et al. Intermittent sulphadoxine- pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: a randomised placebo-controlled trial. Lancet 1999 353: 632 6.
12. Crawley J. Tackling the Problem of Anaemia in Malaria-endemic Regions of Africa. 2005. Available from: http://www.who.int/malaria/rbm/Attachment/ 20040713/MERAanaemiaNov2003.pdf [accessed 22 October 2005].
13. Roll Back Malaria, WHO. Malaria Control Today. Current WHO Recommendations Working Document. 2005. Available from: http://www.who.int/ malaria/docs/MCT_workingpaper.pdf [accessed 24 October 2005].
14. Schellenberg D, Menendez C, Kahigwa E et al. Intermittent treatment for malaria and anaemia control at time of routine vaccinations in Tanzanian infants: a randomised, placebo controlled trial. Lancet 2001 357: 1471 7.
15. Schellenberg D, Menendez C, Aponte J et al. Intermittent preventive antimalarial treatment for Tanzanian infants: follow-up to age 2 years of a randomised placebo-controlled trial. Lancet 2005 365: 1481 3.
16. Massaga J, Kitua A, Lemnge M et al. Effect of intermittent treatment with amodiaqine on anaemia and malarial fevers in infants in Tanzania: a randomised placebo-controlled trial. Lancet 2003 361: 1853 60.
17. Verhoef H, West C, Nzyuko S et al. Intermittent administration of iron and sulfadoxine-pyrimethamine to control anaemia in Kenyan children: a randomised controlled trial. Lancet 2002 360: 908 14.
18. Chandramohan D, Owusu-Agyei S, Carneiro I et al. Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana. BMJ 2005 331: 727 33.
19. Desai M, Mei J, Kariuki S et al. Randomised, controlled trial of daily iron supplementation and intermittent sulfadoxine-pyrimethamine for the treatment of mild childhood anaemia in Western Kenya. J. Infect. Dis. 2003 187: 658 66.
20. Macete E, Aide P, Aponte JJ et al. Intermittent preventive treatment for malaria control administered at the time of routine vaccinations in Mozambican infants: a randomized, placebo-controlled trial. J. Infect. Dis. 2006 194: 276 85.
21. O'Meara W, Bremen J, McKenzie E. The promise and potential challenges of intermittent preventive treatment for malaria in infants (IPTi). Malar. J. 2005 4: 33.
22. Cisse B, Sokhna C, Boulanger D et al. Seasonal intermittent preventive treatment with artesunate and sulfadoxine-pyrimethamine for prevention of malaria in Senegalese children: a randomised, placebo-controlled, double-blind trial. Lancet 2006 367: 659 67.
23. IPTi Consortium. Intermittent Preventive Treatment in Infants. 2005. Available from: http://www.ipti-malaria.org/ [accessed 16 October 2005].
24. Taylor W, White N. Antimalarial drug toxicity: a review. Drug Saf. 2004 27: 25 61.
25. Prudhomme O'Meara W, Smith DL, McKenzie FE. Potential impact of intermittent preventive treatment (IPT) on spread of drug-resistant malaria. PLoS Med. 2006 3: e141.
26. Bloland P, Boriga D, Ruebush T et al. Longitudinal cohort study of the epidemiology of malaria infections in an area of intense malaria transmission II. Descriptive epidemiology of malaria infection and disease among children. Am. J. Trop. Med. Hyg. 1999 60: 641 8.
27. Pasvol G, Weatherall D, Wilson R, Smith D, Gilles H. Fetal haemoglobin and malaria. Lancet 1976 307: 1269 72.
28. Riley E, Wagner G, Ofori M et al. Lack of association between maternal antibody and protection of african infants from malaria infection. Infect. Immun. 2000 68: 5856 63.
29. Rosen JB, Breman JG. Malaria intermittent preventive treatment in infants, chemoprophylaxis, and childhood vaccinations. Lancet 2004 363: 1386 8.
30. Lengeler C. Insecticide-treated bed nets and curtains for preventing malaria. Cochrane Database Syst. Rev. 2004 2: CD000363.
31. Roll Back Malaria. Scaling up Insecticide-treated Netting Programmes in Africa. 2005. Available from: http://www.rollbackmalaria.org/partnership/wg/ wg_itn/docs/WINITN_StrategicFramework.pdf [accessed 23 October 2005].
32. Mathanga D, Campbell C, Taylor T, Barlow R, Wilson M. Reduction of childhood malaria by social marketing of insecticide-treated nets: a case-control study of effectiveness in Malawi. Am. J. Trop. Med. Hyg. 2005 73: 622 5.
33. Moorthy V, Good M, Hill A. Malaria vaccine developments. Lancet 2004 363: 150 6.
34. Greenwood B. Malaria vaccines, evaluation and implementation. Acta Trop. 2005 95: 298 304.
35. Gomes M, Crawley J, Duclos P, Young M. Malaria Intermittent Treatment in Infants. 2005. Available from: http://www.who.int/tdr/publications/tdrnews/ news68/malaria-treatment.htm#refs [accessed 18 October 2005].
36. Bates I. Presumptive malaria treatment in immunisation programmes. Lancet 2005 365: 1443.
37. Egan A, Crawley J, Schellenberg D, on behalf of the IPTi Consortium. Intermittent preventive treatment for malaria control in infants: moving towards evidence-based policy and public health action. Trop. Med. Int. Health 2005 10: 815 17.